CD8A and COVID-19: The public TCR exhibits a high affinity within the range of other potent anti-viral CD8+ T cells [7], and finally, we report here that in COVID-19 recovered individuals, there is a polyfunctional response from CD8+ T cell stimulated with the YLQ peptide.